XGN — Exagen Inc · rev $37.2M

Exagen Inc (XGN) is a diagnostics & research company listed on US.

Latest reported XGN revenue for 2026-06-30 was $37.2M. Net income was -$7.2M. XGN currently screens at market cap $154.1M.

Use this XGN page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the XGN quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the XGN SEC filings page. Lician reads the product cache first so this HTML stays unique to Exagen Inc even when a live quote feed is slow.

Exagen Inc latest statements (FY2025)

Latest cached year on this hub. Full XGN income, balance, and cash tables.

  • Revenue$66.6M
  • Net Income-$20.0M
  • Total Assets$58.0M
  • Total Debt$0
  • Free Cash Flow-$14.3M

XGN recent filings